Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

[Cancer stem cells in pediatric brain tumors].

Nakano I, Hemmati HD, Kornblum HI.

No Shinkei Geka. 2004 Aug;32(8):827-34. Review. Japanese.

PMID:
15478649
2.

Brain tumor stem cells.

Nakano I, Kornblum HI.

Pediatr Res. 2006 Apr;59(4 Pt 2):54R-8R. Review.

PMID:
16549549
3.

Cancerous stem cells can arise from pediatric brain tumors.

Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, Kornblum HI.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83.

4.

Pten signaling in gliomas.

Knobbe CB, Merlo A, Reifenberger G.

Neuro Oncol. 2002 Jul;4(3):196-211. Review.

5.

Translational research strategies applied to glioma therapeutics.

Berger MS, Keles GE.

Clin Neurosurg. 2004;51:203-6. No abstract available.

PMID:
15571146
6.

Cancer stem cells in nervous system tumors.

Singh SK, Clarke ID, Hide T, Dirks PB.

Oncogene. 2004 Sep 20;23(43):7267-73. Review.

PMID:
15378086
7.

mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M, Holland EC.

Neoplasia. 2005 Apr;7(4):356-68.

8.

Glioma-initiating cells and molecular pathology: implications for therapy.

Natsume A, Kinjo S, Yuki K, Kato T, Ohno M, Motomura K, Iwami K, Wakabayashi T.

Brain Tumor Pathol. 2011 Feb;28(1):1-12. doi: 10.1007/s10014-010-0011-3. Review.

PMID:
21274750
9.

In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.

Chesire DR, Ewing CM, Gage WR, Isaacs WB.

Oncogene. 2002 Apr 18;21(17):2679-94.

10.

Pharmacogenomic profiling of the PI3K/PTEN-AKT-mTOR pathway in common human tumors.

Xu G, Zhang W, Bertram P, Zheng XF, McLeod H.

Int J Oncol. 2004 Apr;24(4):893-900.

PMID:
15010827
11.
12.

Mouse induced glioma-initiating cell models and therapeutic targets.

Kondo T.

Anticancer Agents Med Chem. 2010 Jul;10(6):471-80.

PMID:
20879984
13.

Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.

Bruggeman SW, Hulsman D, Tanger E, Buckle T, Blom M, Zevenhoven J, van Tellingen O, van Lohuizen M.

Cancer Cell. 2007 Oct;12(4):328-41.

14.

PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo.

Hambardzumyan D, Becher OJ, Rosenblum MK, Pandolfi PP, Manova-Todorova K, Holland EC.

Genes Dev. 2008 Feb 15;22(4):436-48. doi: 10.1101/gad.1627008.

15.

Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.

Wang H, Wang H, Zhang W, Huang HJ, Liao WS, Fuller GN.

Lab Invest. 2004 Aug;84(8):941-51.

16.

PTEN and TNF-alpha regulation of the intestinal-specific Cdx-2 homeobox gene through a PI3K, PKB/Akt, and NF-kappaB-dependent pathway.

Kim S, Domon-Dell C, Wang Q, Chung DH, Di Cristofano A, Pandolfi PP, Freund JN, Evers BM.

Gastroenterology. 2002 Oct;123(4):1163-78.

PMID:
12360479
17.

Brain cancer stem cells.

Piccirillo SG, Binda E, Fiocco R, Vescovi AL, Shah K.

J Mol Med (Berl). 2009 Nov;87(11):1087-95. doi: 10.1007/s00109-009-0535-3. Review.

PMID:
19784875
18.

Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells.

Lilja JF, Wu D, Reynolds RK, Lin J.

Anticancer Res. 2001 May-Jun;21(3B):1969-74.

PMID:
11497285
20.

Methods for analysis of brain tumor stem cell and neural stem cell self-renewal.

Nakano I, Kornblum HI.

Methods Mol Biol. 2009;568:37-56. doi: 10.1007/978-1-59745-280-9_4.

PMID:
19582420
Items per page

Supplemental Content

Support Center